Recent

% | $
Quotes you view appear here for quick access.

Albany Molecular Research Inc. Message Board

  • amrithebest amrithebest Mar 2, 2010 11:02 AM Flag

    Excelsyn

    “There seems to be a certain amount of criticism, implied and expressed, regarding AMRI's decision to create and acquire operations in India. From my perspective, this is a strategically wise move. Actually, it's brilliant and makes complete & total sense.” (stk-hnter 6, Feb)
    I bet Dr. D’Ambra thinks the towelheads suck. His latest move is really brilliant! Even the guys on the Evonik’s booth were left shaking their heads. They have an expensive badly managed Big Pharma facility that lacks culture. Dr. D’Ambra has found an inexpensive full service laboratory through manufacturing site giving access to the whole of Europe. The only question surrounds the culture that Mr. Shott has in place. However, if it is similar to that established by Mr. Grates (a true Buddy Ryan) it should not take too long to beat them into shape. Not to be sacreligious but, Dr. D’Ambra has once again prove he walks on water.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • "His latest move is really brilliant! Even the guys on the Evonik’s booth were left shaking their heads. . . Not to be sacreligious but, Dr. D’Ambra has once again prove he walks on water." amrithebest 2 Mar, 2010

      Thanks for your post. I was beginning to think that I was talking to myself. However, my good man, you seem to be talking in code. Evonik's booth? Is that a tavern? (I've heard of Miller's Crossing, the bar in Helena, MT) If not, what occasion, when, and where? Please don't be so cryptic.

      Also, I have to ask: are you an insider? Are you trying to drum-up interest in the stock by posting here? I suspect that's what stockstrategist and capcod3 have tried to do. Every time I read one of stockstrategist's silly posts, I get the feeling that he's Tom Sawyer trying to convince me of the wisdom of painting his fence.

      It's good that AMRI is making some moves; and on the surface, this acquisition might not be a bad move. Only time will tell. After all, their chronic problems continue with their facility in Rensselaer -- which is one of several stellar AMRI acquisitions.

      I also have to ask: when was the first time the CEO walked on water? When I spotted that reference, I thought that I had mistakenly strayed onto the Message Board for Google or Apple . . .

      "When investing, pessimism is your friend, euphoria the enemy."
      -- Warren Buffett

      • 1 Reply to stk_hnter
      • "When investing, pessimism is your friend, euphoria the enemy."
        -- Warren Buffett

        I HAD to repeat that quote because it reflects good old fashioned Midwestern homespun wisdom and plain old common sense. Now, because I have an incredibly inflated ego, I'll repeat some of my comments that I have posted here in the past. When one buys stocks, it's not "until death do you part." You need to dump the bad ones. Drop em like a sack of bricks.

        I suspect that the issue here is that you might have bought AMRI when it was trading at ridiculously over-priced levels, somewhere between $25 and $60, and now you're hoping to trigger a stampede of buyers from the Yahoo Message Board to drive the price back up so that you can break even. All of us sod busters with our E*TRADE accounts aren't going to have an impact. It's like using a toothpick to shield yourself in a blizzard.

        If you didn't buy AMRI at ridiculously over-priced levels, then you need to re-evaluate the situation. Put down that bong or opium pipe and detox. Next, turn off that darned hippie music. Next, take off your rose-colored glasses. Next, take a very cold shower. Next, repeat the above cited Warren Buffet quote over and over for about 24 hours. Then look at AMRI with the same degree of skepticism and detachment that you would deploy in scrutinizing a used car.

        For the record, I like David vs Goliath stories. I appreciate mavericks, rebels and creative innovators. As I love sports analogies, I'll use another one. AMRI is like a burned-out QB or pitcher, who will show flashes of non-mediocrity at times but his potential for brilliance is long gone.

        A take-over would be the best thing to happen to AMRI - some large company buys it and breaks up the pieces. However, given the large percentage of shares held by the CEO, that might never happen. Like Charles Foster Kane II, he might keep hanging on hoping for a return to glory. Only his last words won't be "Rosebud," they'll be "$61.625"

        On a side note, kindly refrain from using racist terms when posting. That wasn't very nice!!!

    • poorlake - I'm glad to see that I'm not the only one to have such suspicions . . . LOL

      -- Stock Hunter

    • amrithebest, You are obviously much much much smarter than me. Therefore, I did a little research to gain some knowledge and place your comments into perspective.

      Page 33 of the AMRI investor presentation:
      http://www.amriglobal.com/img/document_files/020110UpdatedInvestorPresentation.pdf

      Evonik is one of 30+ companies that AMRI lists as competitors. According to Evonik's website:

      "Evonik is an international industrial group with a workforce of about 39,000 and activities all over the world. We hold leading positions in the business areas Chemicals, Energy, and Real Estate":
      http://corporate.evonik.com/en/company/at_a_glance/pages/default.aspx

      It would appear that some parts of their group compete on some level with AMRI. That being said, Evonik appears to be rather large and diverse. I have to wonder if the Evonik employees manning their booth at Informex were truly shaking their heads about ARMI's tiny acquisition in the UK or about some guy from AMRI ranting and raving about said tiny acquisition. After all, I shake my head when various fanatics approach me, on the streets of Denver, in their attempts to peddle conspiracy theories or membership in religious cults . . .

    • Why would anyone buy a new business, if the one they have isn't terribly profitable? Mr D'Ambra has done that at least four times.

      • 1 Reply to gsrefiner
      • Clearly you asked an excellent question. However, why you have 6 ratings and all 5 stars shows the mentally on this board – they all appear to be shorts. Yes profit has been less than desired for the past 10 years. In part this has been due to adaptations that occurred in the industry and secondly, the building of a sustainable business. Dr. D’Ambra has acquired a number of strategic pieces that are needed to build a Big Pharma business. Entremed was used to build up the pipeline in several therapeutic areas (including unmet medical need areas!) and both AMRI UK and the Rensselaer manufacturing facilities are key to the long term success of the company. In the intervening years, contract manufacturing will provide the revenue to sustain the transformation into a Big Pharma company. Just my 2 cents.

    • Do you not feel any remorse in giving out your two cents into this fantastic company when by your own admission you are clueless in the area where AMRI dominates – Contract Research and Biotechnology. “Not a Biotechnology company” you said in your latest post – read the web site! I was appreciative of your suggestion and took your advice and have to admit you are right. According to my Indian friends dot heads would be more appropriate.

      Also, you have quoted more that once from Buffet (like Dr. D’Ambra a very successful American hero) yet you admit little to no knowledge of this industry. Aside from durable competitive advantage what else did he say (I will give you a clue you stated that you are a former stock holder).

      Sad to hear of the earthquake is this the second coming?

      And behold, the veil of the sanctuary was torn in two from top to bottom. 31 The earth quaked, rocks were split, tombs were opened, and the bodies of many saints who had fallen asleep were raised.
      And coming forth from their tombs after his resurrection, they entered the holy city and appeared too many.

      ~ Matthew 27:51-53

      God bless

    • amrithebest - I'm sorry. I wanted to reply, but when you compared Warren Buffett to the chairman of AMRI, I laughed so hard that I fell out of my chair and hit my forehead on my desk. Let's see . . . you want to compare the CEO (who, in the opinion of some, doesn't understand Wall Street) of a little-known struggling pharma services company with a genius multibillionaire (who made his fortune on Wall Street) whose advice is sought by presidents, world leaders, kings, princes and captains of industry.

      You are too funny for words!

    • Actually, I misspoke because you were using the CEO of a little-known struggling pharma services company as the yardstick by which you were judging the ubergenius multibillionaire, which in reality is even funnier! ROTFLMAO!!!

    • "Do you not feel any remorse in giving out your two cents into this fantastic company when by your own admission you are clueless in the area where AMRI dominates – Contract Research and Biotechnology." - amrithebest

      Is that question a joke?

      First, you are distorting my comments. I wrote: "I am a not a specialist, never claimed to know the industry that well." I never said that I was clueless - except about your cryptic reference to Informex.

      Second, as a praise-gushing acolyte, you are missing the point: "It's business. It's not personal." It's not as if anything I write will have the slightest impact on the company or stock price. You can't start a rally by clicking your heels and saying, "There's no stock like AMRI."

      Third, here's more than 2 cents: during the past 12 months AMRI has underperformed the S&P500 by about 50 percentage points. 50!!! As the market and prospects for the US economy have rebounded, AMRI has languished:
      http://finance.yahoo.com/echarts?s=AMRI#chart3:symbol=amri;range=1y;compare=^gspc;indicator=volume;charttype=line;crosshair=on;ohlcvalues=0;logscale=on;source=undefined

      Fourth, please elaborate on how you define the word "dominate." You must be using a version other than current English or you are describing an alternate universe.

      Fifth, the fact that I didn't know about Informex is irrelevant. Related to the 4th point, please conduct research to see if AMRI is dominant (in terms of revenues, therapeutic targets, market cap, etc) versus a short list of Biotech companies that I selected at random from Yahoo (A-H in the alphabet):

      Amgen
      Celgene
      Cerus
      Genzyme
      Gilead
      Human Genome Sciences

      Sixth, you are an insider trying to inflate the image of AMRI in an attempt to increase buying interest and influence the stock price. Here is one of the dozens of stories regarding Whole Foods/John Mackey:

      http://seekingalpha.com/article/40816-whole-foods-ceo-john-mackey-makes-a-mind-boggling-mistake

      Or, you could be a troll, which makes sense given your racist comments.

      '"Not a Biotechnology company" you said in your latest post – read the web site!' - amrithebest

      Yes!!! I read the website!!! I stand by my view: AMRI is not a Biotech stock, it's a pharma services stock with a tiny pipeline on the side. One of my friends owns a Knowshon Moreno jersey, but no matter how many times he wears it, he can't run as fast as Knowshon.

      Here is a list of Biotechs from Yahoo!:
      http://biz.yahoo.com/ic/515_cl_all.html

      amrithebest - it is funny how you cherry pick comments in a futile attempt to find flaws. At the same time, you toss around generalities and exaggerations but you completely avoid addressing major questions and issues.

    • dude!

      This is Amrithebest you are talking to.

      you should read his posts from 2004-2005 to see how insane he is. I guarantee you will continue with your ROTLFMAO.

    • sackshapiro,

      Thanks for your reply LOL! Do you think that he is a troll or is he a delusional cheerleader hoping to trigger wave upon wave of buy orders based on his Pollyanna-esque posts?

      Stock Hunter

    • View More Messages
 
AMRI
18.99-0.09(-0.47%)Apr 27 4:00 PMEDT